| abstract |
The invention relates to the stabilized amorphous form of 4- (4-methylpiperazin-1-ylmethyl) -N- [4-methyl-3- (4- (pyridin-3-yl) -pyrimidin-2-ylamino-) phenyl] - benzamide, with pharmaceutical compositions such as capsules or tablets containing this form, the use of this form in diagnostic methods or preferably for the treatment of warm-blooded animals, particularly in humans, and the use of these stabilizing agents the amorphous form of imativine mesylate as an intermediate for the manufacture of pharmaceuticals material compositions. |